Interrelationships exist between many endocrine organs (Asano 1965) . The most well-known are the effects of the pituitary on the peripheral endocrines by way of its trophic hormones. However, interactions between many glands exist; for example, the adrenals and thyroid affect each other (Tullner 1963 ) and both may influence secretion from the gonads. Initially, endocrine manipulations influence the endocrine milieu and sometimes this will lead either directly or indirectly to alterations of tumour growth.
Cellular actionsof hormones
Hormones can affect dependent tissues either indirectly by changes of nutrition, blood supply, immune status or general systemic metabolism, or they can have direct effects at a cellular level. Such direct effects can occur in one of two ways. Some hormones, especially polypeptides and amines, activate adenyl-cyclase which in tum promotes the formation of cyclic adenosine monophosphate and related substances, which alter the characteristic metabolic processes of the particular cell. Other hormones, like steroids, diffuse through the cellular membrane and combine with cytoplasmic receptors to form specific complexes which are then transferred to the cell nucleus. Similar mechanisms presumably operate in neoplastic cells which are hormone dependent. Both oestrogen and androgen receptors have been identified in breast carcinoma tissues from animals and man (Nagai & Longcope 1971 , Unhjem & Tveter 1969 .
Endocrine treatment of cancer
There is now considerable evidence that the immune system is implicated in tumour destruction both in laboratory animals and man. Many factors, like diet. age and drugs can affect immunity but an intimate relationship exists between the endocrine and immune systems.
At present, manipulations of the endocrine environment an: accepted treatments for some endocrine-dependent tumours. particularly cancers of the prostate and breast (Welbourn & Castro 1976) .It is generally assumed that hormone treatments act directly on the proliferating neoplastic cells of these tumours, but reports of beneficial effects on tumours, which are not obviously hormonally dependent, make this assumption less clear (Bloom 1973 ).
If changes of endocrine environment alter the host's immune response, some ofthe beneficial effects of endocrine manipulations seen during the clinical treatment of cancer may result. at least in part. from activation of host immunity. There is certainly considerable evidence that endocrine~ependent tumours are immunogenic. for specific antigens have been demonstrated in prostatic cancer tissues and cellular cytotoxicity against human mammary cancer has been I Based on paper read to Sections of Oncology and Urology. 25 November 1976 shown in vitro. Furthermore, prostatic tissues can be damaged by alloantisera, and antibodies to prostatic tissues develop following cryosurgery (Ablin 1972) . More recently, it has been shown that cellular allergic reactions can be induced in the prostate by direct injection of BCG after systemic sensitization (Robinson et al. 1976) .
Immunological destruction of tumours
The immunological mechanisms involved in tumour-cell destruction are not fully understood and there is disagreement about the relative roles of the separate components of the immunological apparatus in this process. It has not been possible to implicate anyone cytotoxic mechanism in the immune elimination of tumours and different mechanisms seem to dominate in varying conditions.
The importance of thymus processes (T lymphocytes) is clearly established, for specifically sensitized T lymphocytes are able to destroy tumour cells both in vitro and in vivo (Alexander & Fairley 1967) . Killer cells (K cells) are tumouricidal in vitro. They have no direct affinity for target-cell antigens but they are triggered to kill by antibody (lymphocyte dependent) bound to the cells. K cells develop independently of the thymus; they are nonphagocytic and do not actively adhere to glass (MacLennan 1972).Some antibodies may destroy tumour cells without the cooperation of cellular mechanisms.
Resistance of animals to tumour parallels reticuloendothelial activity, but the mechanisms involved are not clear. Phagocytic cells exert a critical role, initiating and maintaining immune reactions because of their ability to interact with antigenreactive lymphoid cells. However, they can act directly as cytotoxic effector cells (Evans & Alexander 1972) or they may play an important part in restoring cellular immunity by removing circulating inhibitory substances.
Enlargement of lymphoid tissues follows administration of growth hormone or thyroxine and adrenalectomy or orchidectomy. Cortisone, oestrogen, androgens and cyproterone acetate all cause lymphoid atrophy (Dougherty 1952) .
Oestrogens cause lymphoid tissue atrophy; however, enhancement of natural or induced antibodies have been reported by some, but not all, workers (von Haam & Rosenfeld 1942) . This paradox between structural and functional changes may result from different effects of hormones on different aspects of immune reactivity. Oestrogens cause T-cell depression (Graff et al. 1969 ), but considerably stimulate macrophages (Margarey 1972) . Administration of testosterone is associated with involution of lymphoid tissue (Reinhardt 1943) . It is mildly immunosuppressive, as judged by its ability to cause prolongation of skin allografts and prevention of adjuvant arthritis in male and female mice (Kappas et al. 1963) . Recently cyproterone acetate has been used for treatment of prostatic cancer (Geller et al. 1967) . It reduces the white pulp of the spleen and causes thymic involution, but there is no information on its effects on immunity (Vojtiskova et af. 1976). Adrenalectomy increases thymus and lymph node size. It also increases immunological reactivity as evidenced by acceleration of skin allograft rejection and increased resistance to viral meningitis (Castro & Hamilton 1972) . Orchidectomy also increases immunological thymic and lymph node size (Castro 1974a) . Immunological reactions, like allograft rejection, respond to oxazalone and graft-versus-host reactions that depend upon T cells for their expression are increased (Castro 1974b) . A further important observation is that orchidectomy has protective effects against the induction of subcutaneous sarcomas and the growth of a transplantable subcutaneous sarcoma (Castro 1974c) . A recent study in rats has shown that cell-mediated immunity was depressed after hypophysectomy (Prentice et al. 1976 ).
Thus, hormonal manipulations have considerable effects on the structure and functioning of the immune system. The relationships of these changes to cancer therapy are not clear and the relative importance of these indirect effects of hormones and their direct inhibitory action on dividing tumour cells requires further investigation.
Conclusion
It is generally assumed that endocrine therapies act directly on neoplastic cells. Observations suggest that hormones affect immune responses and these might influence tumour growth. However, the role of hormones in influencing the immune response still awaits full investigation. Hormone therapy may prove to be important therapeutically, not only in tumours which are apparently hormone-dependent, but also for others.
